+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID06527521

Study of Amyloidosis Frequency in Patients Undergoing Trauma Surgery Using a Red Flags Tool

Led by Consorci Sanitari de l'Alt Penedès i Garraf · Updated on 2026-10-27

246

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying how often amyloidosis occurs in patients undergoing trauma surgery. This observational study aims to identify the presence of amyloidosis using a red flags tool among patients who meet specific risk criteria such as older age or certain heart, nerve, kidney, or liver conditions. The study is sponsored by Consorci Sanitari de lAlt Peneds i Garraf. Participants are patients scheduled for trauma surgery who have at least one risk factor for amyloidosis, including being over 65 years old or having a history of certain cardiac, neurological, or organ diseases. The study involves observing these patients during their routine trauma surgery without additional treatments assigned by the study. During the study, participants will undergo evaluations to detect amyloidosis within one month after surgery. Researchers will review medical history, tests such as echocardiography and blood markers, and other clinical data. Participation requires signing informed consent and the ability to cooperate with evaluations. The study excludes those already diagnosed with amyloidosis.

CONDITIONS

Brief Title

Prevalence of Amyloidosis in Trauma Patients

Research Team

L

Lidia Tikhomirova, MD

N

Noemí Casaponsa

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here